(Q46222013)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23392674%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

title

Enhanced proteolytic clearance of plasma Aβ by peripherally administered neprilysin does not result in reduced levels of brain Aβ in mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23392674%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23392674%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

author name string

John R Walker

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23392674%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Reynand Pacoma

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23392674%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

James Watson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23392674%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Weijia Ou

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23392674%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Juliano Alves

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23392674%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Daniel E Mason

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23392674%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Eric C Peters

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23392674%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Hugo D Urbina

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23392674%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Gus Welzel

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23392674%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Alana Althage

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23392674%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Bo Liu

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23392674%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Tove Tuntland

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23392674%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Jennifer L Harris

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23392674%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Andrew M Schumacher

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23392674%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

language of work or name

English

0 references

publication date

1 February 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23392674%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

published in

Journal of Neuroscience

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23392674%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23392674%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23392674%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

page(s)

2457-2464

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23392674%20AND%20SRC:MED&resulttype=core&format=json

Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition

23 February 2020

cites work

1 reference

12 December 2020

Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier

1 reference

12 December 2020

Disappearance rate of catecholamines, total metanephrines, and neuropeptide Y from the plasma of patients after resection of pheochromocytoma

1 reference

12 December 2020

Metabolic regulation of brain Abeta by neprilysin.

1 reference

12 December 2020

Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease

1 reference

12 December 2020

Brain to plasma amyloid-beta efflux: a measure of brain amyloid burden in a mouse model of Alzheimer's disease.

1 reference

12 December 2020

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

1 reference

12 December 2020

Automation of nanoscale microcapillary liquid chromatography-tandem mass spectrometry with a vented column

1 reference

12 December 2020

Cerebral hemorrhage after passive anti-Abeta immunotherapy.

1 reference

12 December 2020

Neprilysin gene transfer reduces human amyloid pathology in transgenic mice.

1 reference

12 December 2020

Efflux of human and mouse amyloid β proteins 1–40 and 1–42 from brain: impairment in a mouse model of alzheimer's disease

1 reference

12 December 2020

Clearing amyloid through the blood-brain barrier

1 reference

12 December 2020

Somatostatin regulates brain amyloid beta peptide Abeta42 through modulation of proteolytic degradation.

1 reference

12 December 2020

P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model

1 reference

12 December 2020

Identification and characterization of neutral endopeptidase in endothelial cells from venous or arterial origins

1 reference

12 December 2020

Inhibition of neprilysin by infusion of thiorphan into the hippocampus causes an accumulation of amyloid Beta and impairment of learning and memory

1 reference

12 December 2020

Insights into the mechanisms of action of anti-Abeta antibodies in Alzheimer's disease mouse models.

1 reference

12 December 2020

Reduced circulating levels of angiotensin-(1--7) in systemic sclerosis: a new pathway in the dysregulation of endothelial-dependent vascular tone control

1 reference

12 December 2020

Blood-brain barrier impairment in Alzheimer disease: stability and functional significance

1 reference

12 December 2020

Rodent A beta modulates the solubility and distribution of amyloid deposits in transgenic mice

1 reference

12 December 2020

Fibrin deposition accelerates neurovascular damage and neuroinflammation in mouse models of Alzheimer's disease

1 reference

12 December 2020

Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory

1 reference

12 December 2020

Transient gene expression in mammalian cells grown in serum-free suspension culture

1 reference

12 December 2020

Peripheral amyloid-beta levels regulate amyloid-beta clearance from the central nervous system

1 reference

12 December 2020

Quantitative and mechanistic studies of Abeta immunotherapy

1 reference

12 December 2020

Robust amyloid clearance in a mouse model of Alzheimer's disease provides novel insights into the mechanism of amyloid-beta immunotherapy

1 reference

12 December 2020

The second-generation active Aβ immunotherapy CAD106 reduces amyloid accumulation in APP transgenic mice while minimizing potential side effects.

1 reference

12 December 2020

Amyloid-beta transporter expression at the blood-CSF barrier is age-dependent

1 reference

12 December 2020

Neurovascular dysfunction and faulty amyloid β-peptide clearance in Alzheimer disease

1 reference

12 December 2020

Metabolic clearance rate and plasma half life of alpha-human atrial natriuretic peptide in man

1 reference

12 December 2020

Amyloid plaque core protein in Alzheimer disease and Down syndrome

1 reference

12 December 2020

Neutral endopeptidase can hydrolyze beta-amyloid(1-40) but shows no effect on beta-amyloid precursor protein metabolism

1 reference

12 December 2020

Blood-brain barrier transport of circulating Alzheimer's amyloid beta

1 reference

12 December 2020

Fate of cerebrospinal fluid-borne amyloid beta-peptide: rapid clearance into blood and appreciable accumulation by cerebral arteries.

1 reference

12 December 2020

Intra-arterial infusion of [125I]A beta 1-40 labels amyloid deposits in the aged primate brain in vivo.

1 reference

12 December 2020

Permeability and residual plasma volume of human, Dutch variant, and rat amyloid beta-protein 1-40 at the blood-brain barrier

1 reference

12 December 2020

Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology

1 reference

12 December 2020

Cerebrovascular accumulation and increased blood-brain barrier permeability to circulating Alzheimer's amyloid beta peptide in aged squirrel monkey with cerebral amyloid angiopathy

1 reference

12 December 2020

10.1523/JNEUROSCI.3407-12.2013

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23392674%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23392674%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

PubMed publication ID

23392674

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23392674%20AND%20SRC:MED&resulttype=core&format=json